| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amphastar Pharmaceuticals, Inc. (AMPH) has 7 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. AMPH is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.00M | $59.22M | - | |
| CFO | 177.0K | $3.49M | - | |
| VP | 172.8K | $3.41M | - | |
| VP | 122.9K | $2.43M | - | |
| Dir | 71.4K | $1.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2018 | Peters William J52 | CFO, SVP &Treasurer | Sell | 2,407 | $17.59 | $42,332.87 | -2.7% | |
| Aug 14, 2018 | Prins Richard K61 | Director | Sale+OE | 10,000 | $17.82 | $178,180.00 | -22.0% | |
| Jul 11, 2018 | Shandell Jason B. | President And General Counsel | Sell | 14,399 | $16.77 | $241,422.27 | -6.7% | |
| Jul 9, 2018 | Peters William J52 | CFO, SVP &Treasurer | Sell | 3,250 | $16.46 | $53,497.92 | -3.5% | |
| Jun 12, 2018 | Zasloff Michael A53 | Director | Sell | 15,000 | $16.52 | $247,842.00 | -33.4% | |
| May 16, 2018 | Zhang Jack Y.45 | CEO &Chief Scientific Officer | Buy | 40,000 | $16.07 | $642,823.50 | +1.0% | |
| Mar 20, 2018 | Shandell Jason B. | President And General Counsel | Sell | 20,000 | $19.43 | $388,638.00 | -4.2% | |
| Mar 15, 2018 | Prins Richard K61 | Director | Sale+OE | 16,598 | $19.90 | $330,318.46 | -36.5% | |
| Mar 14, 2018 | Shandell Jason B. | President And General Counsel | Sale+OE | 700 | $20.45 | $14,315.00 | -0.2% | |
| Mar 13, 2018 | Peters William J52 | CFO, SVP &Treasurer | Sale+OE | 19,801 | $20.10 | $398,004.06 | -20.2% |